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Abstract
Background: The main objective of this study was to assess the effectiveness of integrating the use of cell-phones
into a routine malaria prevention and control programme, to improve the management of malaria cases among an
under-served population in a border area. The module for disease and treatment monitoring of malaria (DTMM)
consisted of case investigation and case follow-up for treatment compliance and patients’ symptoms.
Methods: The module combining web-based and mobile technologies was developed as a proof of concept, in
an attempt to replace the existing manual, paper-based activities that malaria staff used in treating and caring for
malaria patients in the villages for which they were responsible. After a patient was detected and registered onto
the system, case-investigation and treatment details were recorded into the malaria database. A follow-up schedule
was generated, and the patient’s status was updated when the malaria staff conducted their routine home visits,
using mobile phones loaded with the follow-up application module. The module also generated text and graph
messages for a summary of malaria cases and basic statistics, and automatically fed to predetermined malaria
personnel for situation analysis. Following standard public-health practices, access to the patient database was
strictly limited to authorized personnel in charge of patient case management.
Results: The DTMM module was developed and implemented at the trial site in late November 2008, and was
fully functioning in 2009. The system captured 534 malaria patients in 2009. Compared to paper-based data in
2004-2008, the mobile-phone-based case follow-up rates by malaria staff improved significantly. The follow-up rates
for both Thai and migrant patients were about 94-99% on Day 7 (Plasmodium falciparum) and Day 14 (Plasmodium
vivax) and maintained at 84-93% on Day 90. Adherence to anti-malarial drug therapy, based on self-reporting,
showed high completion rate for P. falciparum-infected cases, but lower rate for P. vivax cases. Patients’ symptoms
were captured onto the mobile phone during each follow-up visit, either during the home visit or at Malaria Clinic;
most patients had headache, muscle pain, and fatigue, and some had fever within the first follow-up day (day7/14)
after the first anti-malarial drug dose.
Conclusions: The module was successfully integrated and functioned as part of the malaria prevention and
control programme. Despite the bias inherent in sensitizing malaria workers to perform active case follow-up using
the mobile device, the study proved for its feasibility and the extent to which community healthcare personnel in
the low resource settings could potentially utilize it efficiently to perform routine duties, even in remote areas. The
DTMM has been modified and is currently functioning in seven provinces in a project supported by the WHO and
the Bill & Melinda Gates Foundation, to contain multi-drug resistant malaria on the Thai-Cambodian border.
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The World Health Organization (WHO) has set ulti-
mate goal to fight against malaria towards the elimina-
tion of the disease by which starts with good and
effective malaria control programme [1,2]. Several con-
trol measures and interventions have been developed
and implemented across the region, including mosquito
control, indoor residual spraying, insecticide-treated
nets, prompt and effective treatment, intermittent pre-
ventive prophylaxis, and behavioural change education
[3,4]. One of the key strategies for eliminating malaria is
the prompt identification and treatment of malaria
patients. To achieve this goal, an effective disease-
management system should exist to enable rapid and
accurate malaria case detection in target areas, and
ensure effective treatment. Therefore, an effective sys-
tem should allow case detection for early treatment at
the point-of-care, and real-time case investigation and
active follow-up of positive cases at the community level
[5,6]. Although the vertical control programme adminis-
tered by the Bureau of Vector-borne Diseases (BVBD)
in Thailand is well organized and distributed throughout
epidemic areas across the country, preventive and treat-
ment control measures may not cover fully and effi-
ciently in rural and remote communities. Difficulties in
those communities might include limited service access,
due to poverty and illegal immigration status, which
inhibit villagers’ treatment-seeking behaviours [7].
In the BVBD’s vertical malaria-control programme [8],
malaria-case treatment and care are managed down to the
village level. In villages in epidemic areas, village malaria
volunteers (VMVs) and/or village health volunteers
(VHVs) work at the point-of-care, malaria posts (MPs),
which collaborate with staff at the official malaria clinic
(MC). At the upper levels, treatment and care are moni-
tored vertically by the Vector-borne Disease Unit (VBDU),
Vector-borne Disease Center (VBDC), up to the regional
Offices of Disease Prevention and Control (ODPC), and
BVBD. In passive case detection, the local febrile patients
visit at MC/MP or VBDU office for diagnosis. The VBDU
staff, however, also conduct periodic active case detection
in their responsible villages. The infected cases are regis-
tered and investigated in more detail. According to the
standard malaria case management practices of Thailand’s
Ministry of Public Health (MOPH), medication and fol-
low-up days are different, corresponding with the type of
infection. The first-line drugs for malaria treatment
adopted by the MOPH adhere to the national guidelines
of Thailand and the WHO [9-13]. Typical uncomplicated
Plasmodium falciparum cases are treated with three days
of artesunate, plus mefloquine on day2 and day3; with
recommended follow-up at days 7 and 28, with additional
days 60 and 90 [13-16]. For typical Plasmodium vivax
malaria cases, patients are treated according to recom-
mended WHO and Thai MOPH practices, with chloro-
quine for three days and a 14-day course of primaquine to
prevent relapse; with recommended follow-up on days 14,
28, 60, and 90 [14,17-19].
A major challenge for malaria-control programme is
the assurance of prompt and effective treatment. It has
been suggested in the literature that monitoring of
prompt diagnosis and effective management of acute
clinical episodes with anti-malarial drugs are crucial to
reducing morbidity and mortality [20-22]. The WHO
suggests that standard guidelines on duration of follow-
up for safety monitoring are needed in different regions
[11,23]. In Thailand, designated malaria staff routinely
assess safety and tolerability, and monitor clinical fail-
ures, in accord with WHO guidelines. Strategies to pro-
mote patient adherence would improve drug
performance and thereby might help to prevent the
rapid emergence of drug resistance [24,25].
This study was part of the project Application of Smart
Phone in “Better Border Healthcare Programme” (BBHP)
that was awarded by the Microsoft Research in early 2008.
The main objective of this two-year project was to develop
technology-based healthcare solutions that would increase
the accessibility and affordability of treatment and care
services to the under-served communities [26]. The BBHP
modules were developed in part to correspond with the
United Nations’ Millennium Development Goals (MDG),
and BVBD malarial-control indicators. One MDG target-
ing healthcare services included combating malaria and
other diseases, while the BVBD had set its mission for pre-
vention and control of malaria to eventually eliminate it.
The module for Disease and Treatment Monitoring of
Malaria (DTMM), one part of the BBHP project, was thus
developed in an attempt to find a solution using mobile
technology to alter treatment-seeking behaviours and facil-
itate better treatment and care for malaria patients in low-
resource settings. Mobile technology, particularly the cel-
lular phone, has not only penetrated the daily lives of peo-
ple in metropolitan areas and large rural cities/towns; they
have also become popular among those living in remote
areas. Thus the DTMM combined both web-based and
smart-phone applications to manage malaria treatment
and care activities, integrated into routine case detection
and follow-up at selected MCs and VBDU. The main
objective of this study was to assess the module’s effective-
ness in improving case follow-up and treatment compli-
ance among an under-served population in a border area.
Methods
Setting and study population
The DTMM was implemented in pilot areas of Sai Yok
District, western Kanchanaburi Province, along the
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Page 2 of 14Thai-Myanmar border. The district, with an area of
2,728.922 sq km (1,053.6 sq mi), is divided into seven
sub-districts, including 55 villages; there are 11 health
centers, two sub-district hospitals, two VBDUs, and
three MCs in the district [27,28]. The DTMM study
areas covered three sub-districts (Bongti, Sri Monkol,
and Lum-Sum), 13 main villages, plus some hamlets of
other nearby villages, from which inhabitants sought
treatment under the treatment coverage area of one MC
and one VBDU. Most residents in the area are of Thai,
Karen, Mon, and Myanmar ethnicity, and are farmers,
woodcutters, and laborers. The non-Thai or migrants
were classified as M1, or migrant workers who had been
living or working in Thailand ≥ 6 months; and M2, or
migrant workers who had been living or working in
Thailand < 6 months.
At-risk groups for malaria transmission in the study
area included Thais and migrants who resided along the
border, and also uncontrolled and undocumented cross-
border migrants. The latter group also sought treatment
f r o mt h eM P / M Ci nt h ea r e a[ 2 9 , 3 0 ] .A c c o r d i n gt ot h e
BVBD stratification system [7], the types of transmission
area are divided by control indicators; A1 (perennial
malaria transmission area) is an area where transmission
is reported ≥ 6 months per year; A2 (periodic malaria
transmission area) is an area where transmission is
reported ≤ 5 months per year; B1 (high-risk area) is
where transmission has not been reported within the
last three years, but primary and secondary vectors are
found, and consequently, the area is potentially suitable
for malaria transmission (high and moderate receptivity);
B2 (low risk area) is where transmission has not been
reported within the last three years; neither primary nor
secondary vectors are found, and suspected vectors may
be found (low and non-receptive).
Sai Yok District is located in a region with a tropical
climate, typically with a rainy season in May-November,
when most malaria cases are present; however, cases
have been reported throughout the year in this malaria-
transmission zone. The three sub-districts where the
DTMM was implemented, were classified as A1 areas.
The annual parasite incidence (API) of malaria in Sai
Yok District in 2009 was 17.3/1,000 population; Bongtee
sub-district had the highest API, of 126.1/1,000 popula-
tion [31,32]. It was reported that P. falciparum and P.
vivax were present in roughly equal proportions [31].
DTMM module
The DTMM was developed under the standard software
development life cycle (SDLC) approach to cover
malaria case management at the local community MCs
and VBDU. This innovative module was designed to be
consistent with the existing paper-based workflow to
avoid resistance from changing the ways in which
malaria staff performed their routine treatment and care
activities. To make it more feasible for effective utiliza-
tion in a field setting, some new features were added to
the module while some redundant parts related to data
collection were eliminated. The DTMM adopted mobile
technology-based features to replace the standard
manual paper-based methods of case detection and fol-
low-up in the villages. Figure 1 shows the conceptual
framework and workflow of the DTMM.
The three main functions of the DTMM are case
detection/registry, new case investigation, and case fol-
low-up. The case detection/registry and investigation
functions of the DTMM have been adapted from the
standard paper-based data collection of the infected
patients. In the case-investigation form, details of case
characteristics, type of malaria, and treatment, are col-
lected. After a patient receives medication per standard
treatment guidelines, a follow-up schedule is generated
and updated each time follow-up is performed. Once
the data have been entered into the module, each indivi-
dual case, or list of registered or followed-up patients in
the system, who have visited the MC/VBDU, can be
examined by the responsible staff (see Figure 2).
Responsible malaria staff at the local treatment sites
are provided with mobile phones loaded with the fol-
low-up application module; they use the case-follow-up
function of the DTMM to update the follow-up status
on the schedule date, and capture the locations (coordi-
nates) each time local malaria staff perform routine
home visits. This replaces paper-based case-tracking in
the villages, and supersedes routine map-drawing for
case locations. The DTMM also sends home-visit-
schedule reminder messages directly to responsible local
staff. During a home visit, the DTMM follow-up func-
tion can record the typical clinical symptoms of malaria.
Information can be captured on the phone in areas
without a telephone signal, and malaria-control staff
can later synchronize information onto the system at
the MC/VBDU, or wherever a signal is available (see
Figure 3).
The use of the DTMM allows remote data transfer
technology in both textual and geographic format. On a
weekly basis, the system would generate short message
service (SMS) with a summary of malaria cases, and
automatically feed them to predetermined MC/VBDU
personnel. A map of each scheduled visit can be dis-
played by clicking on the visit schedule table; this helps
to locate cases in the area, and is especially useful for
identifying foreign cases in remote border areas. Maps
of all cases covered by the health service areas may be
seen at the MC, and also at the upper supervisory level.
Summary statistics can be generated to help malaria
authorities make informed decisions and act accordingly
(see Figure 4).
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It should be noted that all patient-management activities
and the database containing information associated with
such activities, were strictly secured and used only by
authorized personnel who were in charge of patient
case-management. The electronic DTMM system main-
tains the same crucial data-integrity and confidentiality
features as the paper-based processes at the local
malaria clinics.
No written informed consent forms were signed by
the patients who visited the malaria clinics, since the
activities were all routine malaria clinic work; however,
the staff had verbally informed the patients and asked
them to return to the clinic, or agree to home visits, as
part of their scheduled follow-up. Data extracted from
the DTMM databases were secondary data with no
identification linked to them. The authors requested
official permission from the BVBD Director to use the
extracted data for analysis. This study protocol was
reviewed and approved by the Ethics Committee of the
Faculty of Topical Medicine, Mahidol University. Elec-
tronic data were encrypted for transfer, to ensure confi-
dentiality and security.
Results
Malaria case investigation
The DTMM module was developed and implemented at
the trial site in late November 2008 and was fully func-
tioning in 2009. During 2009, 534 malaria patients, 324
(61%) Thais, and 210 (39%) migrants, visited the two
malaria clinics in Sai Yok area (Table 1). Almost all of
the migrants were Karen and other minority groups
who resided in Thailand for ≥ 6 months (M1). The per-
centage of patients with P. falciparum (56%) appeared
to be slightly higher than P. vivax (44%) among the
Thais, while the percentages of P. falciparum and P.
vivax were about the same among the migrants. Some
cases had a history of infection, and used to visit the
Figure 1 Conceptual framework and work flow of DTMM.
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Figure 3 Screen shots of case follow-up on mobile phone.
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Page 5 of 14MCs (classified by the local malaria staff as “not cured”
or “re-infected” cases); the percentage of old cases
among the migrants (15.3%) was higher than the Thais
(7.1%).
Over 70% of patients were male; most of them worked
in rice and corn farms in the area. The average age of
the Thai patients (Mean 22.1 ± SD 15.4; Median 19,
Range 83) was significantly different from the migrants
(Mean 31.3 ± SD 16.8; Median 30, Range 77). Among
t h eT h a i s ,m o r ep a t i e n t sw e r e children aged < 10 years
(28%) than among the migrants (9%). By contrast,
among the migrants, more patients were elderly than
among the Thais.
Case investigation by malaria staff, attempting to
explore possible risk factors based on self-reporting,
found that 41% of migrants and 34% of Thais did not
leave their households or current places of residence
before experiencing febrile symptoms; these could be
indigenous cases. Interestingly, self-reports of leaving
the household 1-2 days beforep r e s u m a b l ei n f e c t i o n ,
showed that more migrant patients stayed elsewhere in
the province (47%) than Thais (29%), while more Thais
(36%) traveled across the border than migrants (11%).
Almost everyone owned a bed-net to protect them-
selves from mosquito bite; over half of the families had
> 1 bed-net. About 70% or more of both Thai and
migrant patients reported that they usually slept in a
bed-net when staying in a transmission area. About 50%
of both groups reported that they stayed in a house that
had been sprayed.
Malaria case follow-up
Baseline data were collected for all malaria cases in the
study area, for the years 2004-2008, before implementa-
tion of the DTMM (Table 2). The numbers of both
Thai and migrant malaria patients varied; there
appeared to be more migrant than Thai cases most
years, and an outbreak was observed among migrants in
Figure 4 Screen shots of summary reports & graphs on mobile phone/site workstation.
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Page 6 of 14Table 1 Case investigation of malaria patients in Sai Yok District, 2009
Characteristics Migrant (n = 210) Thai (n = 324)
n% n %
Type of Infection
Species
Plasmodium falciparum 104 49.5 181 55.9
Plasmodium vivax 106 50.5 143 44.1
Type of patient
New case 178 84.8 301 92.9
Old case - not cured 6 2.9 4 1.2
Old case - reinfection 26 12.4 19 5.9
Personal characteristics
Gender
Male 151 71.9 235 72.5
Female 59 28.1 89 27.5
Age Group (Year)
< = 10 19 9.0 91 28.1
11-20 57 27.1 89 27.5
21-30 30 14.3 59 18.2
31-40 35 16.7 45 13.9
41-50 36 17.1 19 5.9
51-60 22 10.5 17 5.2
> = 61 11 5.2 4 1.2
Occupation
Pre-school child 10 4.8 35 10.8
Student 32 15.2 90 27.8
Agricultural - farming 131 62.4 172 53.1
Work in forest - cut wood, hunting 22 10.5 17 5.2
Commercial 8 3.8 3 0.9
Labor 4 1.9 7 2.2
Other 3 1.4 0 0.0
Marital status
Not married 90 42.9 207 63.9
Married 120 57.1 117 35.1
Risk factors
Stayed out of household (before infection)
No 87 41.4 111 34.3
Yes - within town/province 99 47.1 95 29.3
Yes - in Myanmar 24 11.4 116 35.8
Yes - not specified 0 0.0 2 0.6
Own bed-net
Not own any bed-net 7 3.3 7 2.2
Own at least 1 bed-net 203 96.7 317 97.8
Amount of bed-nets in household
1 47 22.4 142 43.8
2-3 147 70.0 165 51.0
4-5 7 3.4 10 3.0
Sleep in bed-net when staying in transmission area
No 64 30.5 75 23.1
Yes 143 68.1 246 75.9
Not specified 3 1,4 3 0.9
Staying in sprayed household
No 98 46.7 154 47.5
Yes 109 51.9 168 51.9
Not specified 3 1.4 2 0.6
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Page 7 of 142008. Case follow-up percentages on Day 7 (for P. falci-
parum), Day 14 (for P. vivax), and Day 28 (both) during
the period 2004-2008 also varied in the range 20-40%
among the Thai cases, but could be < 10% among the
migrants. The follow-up rates on Day 28 were usually
lower than Day 7.
In 2009, after the DTMM had been implemented and
was fully functioning, therew e r e5 3 4m a l a r i ap a t i e n t s ,
285 (53.3%) P. falciparum,a n d2 4 9( 4 6 . 7 % )P. vivax.
Compared with the baseline data, the follow-up rates
collected by malaria staff on their mobile phones
showed significant improvement. The rates for Thai P.
falciparum and P. vivax c a s e sw e r e>9 0 %( r a n g e9 8 -
99%) at first follow-up day (Day 7 or Day 14), to 93% at
the last recommended follow-up day (Day 90) (see Fig-
ure 5). The rates of follow-up among the migrant
patients were lower: 94% on Day 7 to 84% on Day 90
for P. falciparum, and 98% on Day 14 to 85% on Day 90
for P. vivax.
Self-reported adherence to anti-malarial drug therapy
showed high completion rates for P. falciparum
(94.0%) but fairly low rates for P. vivax (42.6%) (see
Table 3). Patients’ symptoms were captured onto the
mobile phones during follow-up visits, either during
home visits or at the MC/MP. At 7 days after the first
anti-malarial drug dose, a high proportion (83%) of P.
falciparum patients reported headache, over half (60%)
reported muscle pain and fatigue, some (15%) had
fever, and about 17% vomited. Similarly at 14 days
after the first anti-malarial drug dose, most P. vivax
patients (72%) reported headache, about half (51%)
reported muscle pain and fatigue, and some (12%) had
fever (Table 3).
The data in the DTMM could also be mapped, using a
geographical information system (GIS). The geographi-
cal locations of cases captured on Day 7 (P. falciparum),
Day 14 (P. vivax)a n dD a y2 8( P. falciparum + P. vivax)
are shown in Figure 6. No spatial or temporal analysis,
Table 2 Malaria case follow-up, 2004-2009
Year P. falciparum P. vivax
Total cases % Follow-up Total cases % Follow-up
Day 7 Day 28 Day 14 Day 28
Thai
2009 181 99.4 98.3 143 97.9 97.9
2008 161 36.7 26.1 110 33.6 26.4
2007 115 32.2 20.9 99 35.4 21.2
2006 133 38.4 22.6 104 24.0 12.5
2005 113 27.4 22.1 81 32.1 19.8
2004 209 36.4 30.1 186 37.1 37.1
Migrant
2009 104 93.9 97.0 106 98.1 98.1
2008 444 25.2 5.6 231 25.1 6.1
2007 293 11.6 12.9 101 5.1 8.9
2006 312 17.9 9.3 106 27.4 13.2
2005 227 19.8 18.5 77 31.2 20.8
2004 205 30.7 32.7 167 35.3 28.7
Figure 5 Complete follow-up rates of P. falciparum and P. vivax patients.
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Page 8 of 14as part of the initial version of DTMM, was used in this
study. However, the simple disease mapping of these
cases at the village location could help malaria staff tar-
get preventive action more accurately within the identi-
fied high-risk zones. Mapping malaria-risk locations
makes it possible to conduct active case management,
allocate priorities in control programmes, and plan
interventions.
Discussion
Malaria cases among border populations
In 2009, in contrast with the previous 5 years, the
numbers of malaria cases among Thais in the study
areas were higher than among migrant cases who had
mostly resided in Thailand ≥ 6m o n t h s .T h ev e r yh i g h
numbers of migrant patients in 2008, pre-DTMM, was
due to the high cross-border population numbers that
particular year. Baseline information during the 5 pre-
DTMM years usually showed more P. falciparum than
P. vivax cases; but for the year 2009, the proportion of
P. falciparum-infected cases was higher among Thais
but similar among migrants. Meanwhile, a history of
malaria infection was lower among Thais than
migrants. These proportions of infection captured
from the DTMM reflected disease burden in the areas
even though it derived only from symptomatic indivi-
duals who came to malaria clinics seeking anti-malarial
treatment. Almost all cases in border areas would seek
treatment at governmental malaria clinics or the dis-
trict hospital, since there was no private hospital in the
area, and anti-malarial drugs are not available in Thai
drug stores. In an epidemiological study conducted in
a low-transmission setting on the Thai-Myanmar bor-
der [33], it was reported that all P. falciparum infec-
tions were symptomatic, but approximately 10% of P.
vivax infections were still asymptomatic. In another
cross-sectional study in intense malaria transmission
districts near the site of this study, along the Thai-
Myanmar border [34], among the surveyed 125
households, 10% were Thai, 42% Mon, and 48% Karen;
about 40% of Thai and Karen migrants and almost
30% of Mon migrants reported having suffered from
malaria at least once.
The age and sex distribution of the malaria patients
reflected the disease situation in the area. Most patients
in both groups were working-aged males who laboured
in rice and corn farms in the area, while some reported
working in forest areas along the border. In a retrospec-
tive study along Thailand’s borders [35], increasing pro-
portions of malaria cases were shown over 12 years
among cross-border migratory foreign workers; these
cases were especially concentrated in districts bordering
Cambodia and Myanmar. This trend suggested that
cross-border seasonal labour might play an important
role in malaria transmission. In the other study of fac-
tors influencing self-reported malaria among migrants
living along the Thai-Myanmar border [34], migrant
working conditions played a major role in acquiring
malaria.
In contrast with their infection status, most Thai and
migrant patients in this study reported that they owned
a bed-net and usually slept in a bed-net when they
stayed in a transmission area. In a study following 3
years’ bed-net use by villagers in Kanchanaburi Province
[36], it was reported that conventional insecticide-
treated mosquito nets (ITN) had been used over the
years by the villagers, but that they needed to be
retreated promptly at 6-month intervals, or they would
only provide 15% protection against malaria vectors.
The results of the current study may reflect the findings
of the bed-net study such that even though patients
claimed to use bed-nets when they stayed in a transmis-
sion area, the ITNs might fail due to being re-treated
improperly. A long-term follow-up study on bed-net use
[36] also reported that ITN implementation at commu-
nity level had several technical, operational, economic,
and social difficulties, and as a result, low re-treatment
rates were observed.
Table 3 Malaria case follow-up for P. falciparum and P. vivax patients, Sai Yok District, 2009
Follow-up On Mobile Phone P. falciparum cases (n = 285) P. vivax cases (n = 249)
n% n %
Complete treatment (self-reported)
No 17 6.0 143 57.4
Yes 268 94.0 106 42.6
Symptoms within the first follow-up day (day 7/day14) post first dose
Fever 42 14.7 29 11.6
Headache 235 82.5 179 71.9
Chill 10 3.5 6 2.4
Muscle Pain/Fatigue 172 60.4 127 51.0
Vomit 49 17.2 16 6.4
Diarrhea 5 1.8 2 0.8
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For self-reported adherence to anti-malarial drug ther-
apy, this study found a completion rate of > 90% for P.
falciparum cases. This markedly rate may due to the
short course of treatment; however, this figure was
based on self-reports, not direct observations, and may
not be completely reliable. In contrast, adherence to
treatment among the P. vivax cases was < 50%, probably
due to the longer treatment course. Similarly, a study of
206 P. vivax patients on the northern Thai-Myanmar
border [37] found 76% did not complete the full medi-
cation course. A study on adherence to treatment
among P. vivax patients found significant differences in
knowledge about malaria and perceptions of the benefits
of anti-malarial drugs between adherent and non-
adherent groups.
Like any public health programme, the success or fail-
ure of a malaria control programme is largely deter-
mined by the effective use of the services offered to the
public. Monitoring the prompt use of effective drugs
would greatly reduce the incidence of severe and com-
plicated disease [22]. Effective, active case monitoring
can also increase the chances of capturing relapse and
reinfection. In this study, the use of mobile phones, as
part of the DTMM, proved effective in increasing case
follow-up rates, in line with the days recommended for
ideal case-management and monitoring (up to day 90).
The follow-up rates for P. falciparum and P. vivax Thai
patients were almost 100% at first follow-up day (Day 7/
14), and were maintained at > 90% to Day 90. Even
though the follow-up rates for migrant patients
appeared lower, at about 85% at Day 90, this could still
be considered a marked success. Case follow-up rates
using the smartphone in the DTMM were much higher
than the five pre-DTMM years. The increases in follow-
up rates for migrant workers has made it a promising
tool for planning malaria prevention and control pro-
grammes in the cross-border multi-drug-resistant
malaria containment project.
However, it is possible that the treatment adherence
and case-follow-up rates observed in this study may be
overestimated. Although the DTMM activities attempted
to mimic the routine malaria prevention and control
programme situation, efforts to conduct home visits by
Figure 6 Screen shots of disease mapping of follow-up cases.
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Page 10 of 14malaria staff may have been more diligent than normal
practices in case management due to sensitizing with
the programme and equipment. Nevertheless, this find-
ing reflects what malaria case management could have
achieved in terms of promoting adherence to therapy
and case monitoring in ideal situation and beyond what
will generally be expected for case follow-up to Day 28.
Monitoring signs and symptoms
During routine follow-up home visits, non-specific
symptoms and signs of malaria (fever, headache, shiver-
ing/chills, muscle pain/fatigue, diarrhea, and vomiting)
were captured on mobile phone. The purpose of this
DTMM feature is to monitor the typical symptom of
malaria which could be cyclical occurrence and to avoid
chance of complicated incident as delay of diagnostic
and treatment may lead to severe complications [38].
Other side-effects and severe adverse events (if any)
were monitored by malaria staff outside the mobile tool.
The information captured by the DTMM smartphone
revealed that patient symptoms from first drug dose to
first follow-up day were similar to those reported in sev-
eral other clinical-trial studies [31,39,40].
These symptoms could also have effect on adherence
to treatment previously discussed. Drug failure might
occur in malaria endemic area by several means includ-
ing, in part, the patients got relief from major clinical
symptoms and thus not adhered to the full course. This
could easily go undetected without an effective follow-
up system. Propagation of resistant parasites could result
in an epidemic without effective case monitoring and
the lack of an early warning module [41].
Conclusions
DTMM usage
The DTMM has shown successfully integrated into the
malaria control programme’s operations at the pilot
sites. Data in the secured database of the module
helped local malaria staff at the MC conduct their
activities. The DTMM has succeeded in providing
information to local malaria staff for routine case-man-
agement activities, and in providing timely summary
reports for situational analysis. The DTMM made data
collection easier at the local clinic, and additional data
were collected on the mobile phone during routine
home visits. With more information collected systema-
tically in the database, this module has allowed the
exploration of clinical outcomes and the generation of
new hypotheses about transmission, and prevention
and control measures. It would also be a useful tool
for intervention studies, since it can collect reliable
and timely variables, and identify cases in study areas.
It has the potential to help determine vulnerable pre-
dictors of malaria outbreaks.
In summary, malaria case-management using the
DTMM appeared to have reached close to the target of
national guideline, especially for case-monitoring and fol-
low-up. By using information from the electronic-based
data capture and data management with an additional
feature of mobile technology for data transfer, follow-up
could even be successfully performed beyond day 28. The
DTMM has made it easier and faster to collect and pro-
cess data closer to real-time, compared with the original
paper-based process. The module removes repetitive data
collection and generates useful reports for malaria con-
trol actions. Malaria staff at the pilot site, who used the
DTMM, expressed satisfaction with the module’s applica-
tions. It should be noted, however, that it required several
meetings and training sessions to familiarize staff with
the DTMM, and to use the smartphone for data collec-
tion in areas with and without mobile telephone service.
Another issue requiring attention is linkage of the
DTMM to the existing healthcare system, making it part
of Thailand MOPH’s routine work practices. This could
be achieved by making the local staff feel ownership and
make use of the data collected locally while be able to
generate the routine reports needed by MOPH.
Module operation and management costs
In quantifying the costs of designing, implementing, and
maintaining this module, certain factors must be taken
into account. The estimates here comprise hardware
and software costs, not personnel costs.
The DTMM was developed by BIOPHICS with sup-
port from a Microsoft Research Award; its concept and
programming parts were posted as open-source. The
DTMM requires a server to manage data processing
(scheduling follow-up appointments and updating visits)
and text message delivery. Currently, the server is
located at BIOPHICS, but this can be put as part of the
existing computer at VBDU or upper levels. In 2009 fig-
ures, the investment cost for the DTMM (minimum for
hardware requirements, including server, workstation,
and tape back-up) is about US $2,500, and software
licenses for Windows and SQL about US $2,500. MC/
VBDU staff enter data into the DTMM system using a
laptop (or workstation) connected to the internet by an
Aircard (maintenance cost about US $20 per month)
with unlimited data package. The SMS cost was about
US $0.03 per message. At least one low-cost smartphone
should be allocated to VBDU staff per operational area;
the prices of smartphones have dropped dramatically
over the year. In 2009, the DTMM smartphone cost
approximately US $300.
Challenges
The results of this study, and epidemiological data from
other studies, show that the prevalence of malaria
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groups requiring attention include hard-to-reach popu-
lations, ethnic minorities, and mobile populations. Sur-
veillance data over the years imply that the provinces
with the highest incidence rate border Myanmar and
Cambodia. Population movements in these areas,
together with high drug pressure, are considered respon-
sible for the development and spread of drug-resistant P.
falciparum malaria [35]. It has been suggested that
efforts to isolate tolerant parasites and eliminate malaria
require more harmonized and aligned multi-country
malaria control and pre-elimination strategies [42].
Thus, in 2008, the WHO and the BVBD of Thailand
MOPH developed a programme to contain multi-drug
resistant malaria along the Thai-Cambodian border. In
this work, recommendations were made to improve
malaria treatment adherence by Directly Observed Treat-
ment (DOT), to implement cross-border strategies to
harmonize malaria-control strategies, and to share infor-
mation on drug resistance and follow-up on patients who
regularly crossed the border [5,42]. One strategy included
an effective surveillance system, which could capture and
manage malaria cases in border areas, by incorporating
such vulnerable populations [5,6,42]. Therefore, the
DTMM was modified and enhanced to be Malaria Infor-
mation System (MIS) with the purpose to expand for
implementation in seven provinces along the Thai-Cam-
bodian border. The modified DTMM (the MIS) is now
functioning particularly in response to emergency con-
tainment and in planning the elimination of tolerant
malaria parasites in the region. The MIS is a collaborative
effort between BIOPHICS and the BVBD of Thailand’s
MOPH, and is funded by WHO and the Bill and Melinda
Gates Foundation (BMGF) for 2009-2010 [43].
The MIS, the modified version of the DTMM, is func-
tioning as a surveillance and case management system
for malaria incidents at the local level. Like any surveil-
lance system, its value for infectious disease is measured
by its ability to provide timely, accurate ‘’data for action’’
to people responsible for effective prevention and con-
trol activities, and by its ability to provide ongoing feed-
back to the primary gatherers of information [44]. It is
believed that long-term and accurate datasets, such as
that provided by the MIS, are essential for prediction
and trend analysis of malaria. In the containment pro-
ject, the web-based and mobile phone systems have
been modified to capture clinical, laboratory, and parasi-
tic outcomes. The enhanced version of the DTMM uti-
lizes more GIS features and spatial analysis which are
essential to focus on scarce resources, improve the effi-
cacy of control, and decrease the burden of disease [45].
The modified DTMM also adds spatio-temporal presen-
tations for decision-making and containment purposes.
Specifically, within the modified DTMM system
launched in the border area, GIS could be useful at both
macro and micro levels in planning the provision of
health infrastructure, mapping disease distribution,
investigating the spatial dynamics of disease transmis-
sion, and modeling health service utilization and disease
control intervention.
The major challenge for success of the system is data
quality, including data integrity, completeness, and time-
liness. Since the system is designed to capture data, in
part, for migrants and hard-to-reach populations, it
should be acknowledged that some malaria infections
may not be contracted at the place of reporting. The
MIS is in the process of enhancement, to enable it to
handle such difficult situations. Dedicated staff were a
crucial factor for success of the DTMM; at minimum,
they should be well-trained in geographical-information
and mobile-technology applications; while this is not dif-
ficult, it cannot be over-emphasized. This is an impor-
tant factor to consider for MIS implementation in new
border areas.
The MIS has now been functioning to the eastern
Thai-Cambodia border, despite its origins on the wes-
tern Thai-Myanmar border. Another challenge is to
expand the modified version of the DTMM to manage a
wider range of endemic areas back on the longer
stretching western border. Strengthening MC and
VBDU infrastructure and additional financial support
are needed in certain locations for sustainability and
implementation at a national level. It is a substantial
challenge to expand and maintain such a system nation-
wide and to eventually be part of and managed by the
Thailand MOPH malaria surveillance team. Moreover,
the system design will need adjustment, so that it is
more modular approach, and more easily adapted for
use beyond Thailand’s borders.
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